{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:49:28Z","timestamp":1761166168643,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI21C0940"],"award-info":[{"award-number":["HI21C0940"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006107","name":"Gil Medical Center, Gachon University","doi-asserted-by":"publisher","award":["FRD2021-24"],"award-info":[{"award-number":["FRD2021-24"]}],"id":[{"id":"10.13039\/501100006107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2017R1C1B5075617","2021R1F1A1052586"],"award-info":[{"award-number":["2017R1C1B5075617","2021R1F1A1052586"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.anndiagpath.2022.151903","type":"journal-article","created":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T20:49:24Z","timestamp":1643575764000},"page":"151903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["TROP-2 and 5hmC expression in follicular-patterned thyroid neoplasm emphasizing tiny well-formed papillae"],"prefix":"10.1016","volume":"57","author":[{"given":"Jae Yeon","family":"Seok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemo","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.anndiagpath.2022.151903_bb0005","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.0386","article-title":"Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors","volume":"2","author":"Nikiforov","year":"2016","journal-title":"JAMA Oncol"},{"year":"2017","series-title":"WHO classification of tumours of endocrine organs","author":"Lloyd","key":"10.1016\/j.anndiagpath.2022.151903_bb0010"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.151903_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/modpathol.2017.130","article-title":"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists","volume":"31","author":"Seethala","year":"2018","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2022.151903_bb0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00268-017-4182-5","article-title":"Clinical safety of renaming encapsulated follicular variant of papillary thyroid carcinoma: is NIFTP truly benign?","volume":"42","author":"Parente","year":"2018","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.151903_bb0025","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/modpathol.2017.9","volume":"30","author":"Cho","year":"2017","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.151903_bb0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/thy.2016.0671","article-title":"Clinical characteristics of subtypes of follicular variant papillary thyroid carcinoma","volume":"28","author":"Kim","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.anndiagpath.2022.151903_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2017.12.027","article-title":"The evolving diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)","volume":"74","author":"Lloyd","year":"2018","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2022.151903_bb0040","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1089\/thy.2019.0328","volume":"29","author":"Xu","year":"2019","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.anndiagpath.2022.151903_bb0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12105-019-01124-z","article-title":"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): an update","volume":"14","author":"Xu","year":"2020","journal-title":"Head Neck Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.151903_bb0050","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/cncy.21848","article-title":"Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?","volume":"125","author":"Brandler","year":"2017","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.151903_bb0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/cncy.21839","article-title":"Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma","volume":"125","author":"Zhao","year":"2017","journal-title":"Cancer Cytopathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2022.151903_bb0060","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1089\/thy.2016.0280","article-title":"Preoperative cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a prospective analysis","volume":"26","author":"Strickland","year":"2016","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.151903_bb0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/his.13363","article-title":"A user's guide to non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)","volume":"72","author":"Hung","year":"2018","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.151903_bb0070","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/his.13401","article-title":"Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma","volume":"72","author":"Kim","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2022.151903_bb0075","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.2147\/OTT.S162447","article-title":"Targeting Trop-2 in solid tumors: future prospects","volume":"12","author":"Zaman","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.151903_bb0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.pathol.2016.04.002","article-title":"TROP-2 immunohistochemistry: a highly accurate method in the differential diagnosis of papillary thyroid carcinoma","volume":"48","author":"Bychkov","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.anndiagpath.2022.151903_bb0085","doi-asserted-by":"crossref","DOI":"10.1177\/2632010X19863047","article-title":"Diagnostic value of TROP-2 and CK19 expression in papillary thyroid carcinoma in both surgical and cytological specimens","volume":"12","author":"Abdou","year":"2019","journal-title":"Clin Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2022.151903_bb0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/IJPM.IJPM_202_18","article-title":"The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions","volume":"62","author":"Sadullahoglu","year":"2019","journal-title":"Indian J Pathol Microbiol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.151903_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000494430","article-title":"Evaluation of diagnostic utility of immunohistochemistry markers of TROP-2 and HBME-1 in the diagnosis of thyroid carcinoma","volume":"8","author":"Zargari","year":"2019","journal-title":"Eur Thyroid J"},{"issue":"8","key":"10.1016\/j.anndiagpath.2022.151903_bb0100","first-page":"4130","article-title":"Overexpression of trophoblast cell surface antigen 2 is associated with BRAF V600E mutation and aggressive behavior in papillary thyroid cancer","volume":"11","author":"Guan","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2022.151903_bb0105","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s00405-018-5045-x","article-title":"The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma","volume":"275","author":"Yang","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.151903_bb0110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/dc.23382","article-title":"TROP-2 expression in papillary thyroid carcinoma: potential diagnostic utility","volume":"44","author":"Simms","year":"2016","journal-title":"Diagn Cytopathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.151903_bb0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/cyt.12196","article-title":"TROP-2 expression in papillary thyroid cancer: a preliminary cyto-histological study","volume":"26","author":"Addati","year":"2015","journal-title":"Cytopathology"},{"issue":"7310","key":"10.1016\/j.anndiagpath.2022.151903_bb0120","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nature09303","article-title":"Role of tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification","volume":"466","author":"Ito","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.151903_bb0125","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.7150\/jca.38283","article-title":"Prognostic value of downregulated 5-hydroxymethylcytosine expression in renal cell carcinoma: a 10 year follow-up retrospective study","volume":"11","author":"Chen","year":"2020","journal-title":"J Cancer"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.151903_bb0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neo.2020.01.001","article-title":"Epigenomic analysis of 5-hydroxymethylcytosine (5hmC) reveals novel DNA methylation markers for lung cancers","volume":"22","author":"Wang","year":"2020","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.151903_bb0135","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41379-018-0159-7","article-title":"Immunohistochemical evaluation of nuclear 5-hydroxymethylcytosine (5-hmC) accurately distinguishes malignant pleural mesothelioma from benign mesothelial proliferations","volume":"32","author":"Chapel","year":"2019","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.151903_bb0140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1158\/0008-5472.CAN-18-1214","article-title":"TET2-dependent hydroxymethylome plasticity reduces melanoma initiation and progression","volume":"79","author":"Bonvin","year":"2019","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.151903_bb0145","first-page":"2304","article-title":"5-hydroxymethylcytosine as a potential epigenetic biomarker in papillary thyroid carcinoma","volume":"18","author":"Tong","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.anndiagpath.2022.151903_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3909610","article-title":"TET1 is a tumor suppressor that inhibits papillary thyroid carcinoma cell migration and invasion","volume":"2020","author":"Yu","year":"2020","journal-title":"Int J Endocrinol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.151903_bb0155","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1066896920978597","article-title":"TROP-2, 5hmC, and IDH1 expression in anaplastic thyroid carcinoma","volume":"29","author":"Seok","year":"2021","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.151903_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4132\/KoreanJPathol.2012.46.1.61","article-title":"Detection of BRAF(V600E) mutations in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR: a comparison with direct sequencing","volume":"46","author":"Jeong","year":"2012","journal-title":"Kor J Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.151903_bb0165","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.anndiagpath.2022.151903_bb0170","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/01.pas.0000135519.34847.f6","article-title":"Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma","volume":"28","author":"Lloyd","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.151903_bb0175","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12022-018-9520-0","article-title":"An international interobserver variability reporting of the nuclear scoring criteria to diagnose noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a validation study","volume":"29","author":"Thompson","year":"2018","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.151903_bb0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12020-017-1484-1","article-title":"Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category?","volume":"59","author":"Xu","year":"2018","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.151903_bb0185","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1089\/thy.2016.0649","article-title":"Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features","volume":"27","author":"Xu","year":"2017","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.151903_bb0190","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12022-018-9519-6","article-title":"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in asian practice: perspectives for surgical pathology and cytopathology","volume":"29","author":"Bychkov","year":"2018","journal-title":"Endocr Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:34:48Z","timestamp":1761078888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913422000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":38,"alternative-id":["S1092913422000053"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.151903","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TROP-2 and 5hmC expression in follicular-patterned thyroid neoplasm emphasizing tiny well-formed papillae","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.151903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151903"}}